Molina Healthcare, Inc. MOH
We take great care to ensure that the data presented and summarized in this overview for MOLINA HEALTHCARE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MOH
View all-
Vanguard Group Inc Valley Forge, PA6.6MShares$2.29 Billion0.05% of portfolio
-
Capital World Investors Los Angeles, CA5.25MShares$1.83 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY4.85MShares$1.69 Billion0.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.79MShares$1.32 Billion0.19% of portfolio
-
Wellington Management Group LLP Boston, MA3.44MShares$1.19 Billion0.26% of portfolio
-
State Street Corp Boston, MA2.59MShares$899 Million0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.43MShares$845 Million0.23% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.98MShares$687 Million0.5% of portfolio
-
Capital International Investors Los Angeles, CA1.67MShares$579 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.34MShares$466 Million0.05% of portfolio
Latest Institutional Activity in MOH
Top Purchases
Top Sells
About MOH
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Insider Transactions at MOH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
136
+2.06%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+5.69%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
136
+0.72%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+0.9%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+1.18%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+3.56%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+2.3%
|
$54,944
$404.2 P/Share
|
Apr 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
136
+0.78%
|
$54,944
$404.2 P/Share
|
Mar 01
2024
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-2.48%
|
$65,790
$387.21 P/Share
|
Mar 01
2024
|
Debra Bacon EVP, Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
2,273
+24.93%
|
$879,651
$387.21 P/Share
|
Mar 01
2024
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,122
+10.92%
|
$6,239,214
$387.21 P/Share
|
Mar 01
2024
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,938
-4.66%
|
$2,298,006
$387.21 P/Share
|
Mar 01
2024
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,779
+8.74%
|
$5,719,473
$387.21 P/Share
|
Mar 01
2024
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,338
-5.58%
|
$3,226,806
$387.21 P/Share
|
Mar 01
2024
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,579
+9.74%
|
$33,119,073
$387.21 P/Share
|
Mar 01
2024
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,443
-7.88%
|
$23,004,441
$387.21 P/Share
|
Mar 01
2024
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,228
+16.59%
|
$8,215,236
$387.16 P/Share
|
Mar 01
2024
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,165
-10.07%
|
$3,933,855
$387.21 P/Share
|
Mar 01
2024
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,304
+6.95%
|
$891,648
$387.18 P/Share
|
Mar 01
2024
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
966
-4.92%
|
$373,842
$387.21 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 148K shares |
---|
Payment of exercise price or tax liability | 85K shares |
---|---|
Open market or private sale | 38.9K shares |
Bona fide gift | 5.7K shares |